期刊文献+

10例孕妇血浆中胎儿游离DNA-STR位点检测分析 被引量:3

Research on short tandem repeat of free-fetal DNA in maternal plasma
在线阅读 下载PDF
导出
摘要 目的:探索短串连重复序列(STR)多位点检测孕妇血浆中胎儿游离DNA的可行性。方法:改进QIAamp离心柱型DNA提取方法提取10例孕中期孕妇血浆中总游离DNA,进行D3S1358、D13S317、CSF1PO、D12S391、D6S477、VWA6个STR位点扩增,并以孕妇与胎儿羊水细胞基因组DNA为对照,变性聚丙烯酰胺凝胶电泳分析胎儿游离DNA提取效果及检测效率。结果:10例孕中期孕妇血浆样本共检测位点60个,检出有结果位点44个,除去母体与胎儿DNA基因型完全一致的14个位点,剩余的30个位点中,18个位点成功检出胎儿DNA基因型,检出率30%。检出率最高的位点是D13S317和D12S391。结论:STR多位点的扩增可以检测得出胎儿特异性DNA序列,有望应用于无创伤性产前遗传性疾病的诊断和法医学亲子鉴定中。 Objective:To study the feasibility of detecting free-fetal DNA in maternal plasma by multiplex short tadem repeat (STR) loci amplification. Methods:Plasma total DNA extracted from 10 medium pregnancy women by improved DNA isolation method were detected to analyze genotype by multiplex STR amplification. Then the extraction efficiency and rate of assay was analyzed using DNA-PAGE (polyacrylamide gel electrophoresis) in comparison with the matemal and fetal genome DNA. Results:Of all the 60 loci detected in 10 medium pregnancy women plasma,44 loci have results. Except the 14 loci which matemal and fetal DNA genetypes were completely same,free-fetal DNA in maternal plasma were detected in 18 of 30 STR loci,the rate of detection was 30%. D13S317 and D12S391 have the maximal detection rate. Conclusion:Multiplex STR loci amplification can detect free-fetal specificity genotype in maternal plasma, which may have expectation for noninvasive prenatal diagnosis of certain hereditary diseases.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2008年第4期522-526,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省卫生厅135重点人才基金(RC2002052)
关键词 胎儿游离DNA STR 产前诊断 free-fetal DNA short tandem repeat prenatal diagnosis
  • 相关文献

参考文献1

二级参考文献38

  • 1刘福民 ,冯霞 ,王秀英 ,王文 ,叶月仙 ,陈红 .荧光定量PCR检测孕妇血浆中胎儿DNA的研究[J].中华围产医学杂志,2005,8(6):380-383. 被引量:5
  • 2邓志辉,李茜,李大成,王大明,高素青,吴国光.中国南方汉族群体九个短片段长度Y-STR基因座的遗传多态性及其法医学应用[J].中华医学遗传学杂志,2006,23(4):470-474. 被引量:13
  • 3Tang NL, Leung TN, Zhang J, et al. Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clin Chem, 1999,45 : 2033-2055.
  • 4Farina A, LeShane ES, Lambert-Messerlian GM, et al. Evaluation of cellfree. fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem, 2003, 49: 239-242.
  • 5Wataganara T, LeShane ES, Farina A, et al. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Hum Genet, 2003, 112:204-208.
  • 6Faas BH, Beuling EA, Christiaens GC, et al. Detection of fetal RHD-specific sequences in maternal plasma. Lancet, 1998, 352:1196.
  • 7Zhong XY, Holzgreve W, Hahn S. Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. Br J Obstet Gynecol, 2000, 107:766-769.
  • 8Pertl B, Sekizawa A, Samura O, et al. Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats. Hunt Genet, 2000,106:45-49.
  • 9Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet, 1997, 350:485-487.
  • 10Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res, 1977, 37 : 646-650.

共引文献4

同被引文献35

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部